<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Clincal Exome Table</title>
  <link rel="stylesheet" href="style.css">
  <script src="https://kit.fontawesome.com/c993345b5e.js" crossorigin="anonymous"></script>
</head>
<body>
    <div class="container-fluid header-wrapper">
		<div class="col-xs-8">
			<div class="logo">
				<img src="pic2.png" alt="logo">
			</div>
			<span class="logotext"><b>Gene Coverage Metrics</b></span>
		</div>
	</div>
  <div class="container">
    
    <table id="dataTable">
      <thead>

							<tr>
								<td colspan="3">
									<h1 style="float: left;">Gene Coverage Table <br><span>(ADVAT Focus Carrier Screening Panel)</span></h1>
									<input type="text" id="searchInput" placeholder="Search...">
									<a href="ADVAT_gene.xlsx" download="ADVAT"><i class="fa-solid fa-download"></i></a>
								</td>
								</td>
							</tr>
							<tr class="header">
<tr class="header">
								<th>S.No</th>
								<th>Condition</th>
								<th>Gene</th>
                                <th>CNV Target Plus</th>
							
							</tr>
						
        
      </thead>
      <tbody>

        <tr>
            <td>1</td>
            <td>Ataxia-Telangiectasia</td>
            <td>ATM</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>2</td>
            <td>Bardet-Biedl Syndrome 4</td>
            <td>BBS4</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>3</td>
            <td>Mental retardation, autosomal recessive 3</td>
            <td>CC2D1A</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>4</td>
            <td>Cystic Fibrosis</td>
            <td>CFTR</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>5</td>
            <td>Ceroid Lipofuscinosis, Neuronal, 3</td>
            <td>CLN3</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>6</td>
            <td>Cystinosis</td>
            <td>CTNS</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>7</td>
            <td>Duchenne/Becker Muscular Dystrophy</td>
            <td>DMD</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>8</td>
            <td>Fanconi Anemia, Group A</td>
            <td>FANCA</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>9</td>
            <td>Fanconi Anemia, Group C</td>
            <td>FANCC</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>10</td>
            <td>Glycogen Storage Disease, Type II (Pompe Disease)</td>
            <td>GAA</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>11</td>
            <td>Krabbe Disease</td>
            <td>GALC</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>12</td>
            <td>Galactosemia</td>
            <td>GALT</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>13</td>
            <td>Isolated growth hormone deficiency, Type IA/II</td>
            <td>GH1</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>14</td>
            <td>Non-Syndromic Hearing Loss (a.k.a. Connexin 26)</td>
            <td>GJB2</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>15</td>
            <td>Non-Syndromic Hearing Loss (a.k.a. Connexin 30)</td>
            <td>GJB6</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>16</td>
            <td>Fabry Disease</td>
            <td>GLA</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>17</td>
            <td>Beta-Hemoglobinopathies</td>
            <td>HBB</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>18</td>
            <td>Tay-Sachs Disease</td>
            <td>HEXA</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>19</td>
            <td>Glanzmann thrombasthenia</td>
            <td>ITGB3</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>20</td>
            <td>Mucolipidosis, Type IV</td>
            <td>MCOLN1</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>21</td>
            <td>Nemaline Myopathy, NEB-Related</td>
            <td>NEB</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>22</td>
            <td>Phenylketonuria</td>
            <td>PAH</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>23</td>
            <td>Usher Syndrome, Type 1F</td>
            <td>PCDH15</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>24</td>
            <td>Myasthenic syndrome, congenital, 22</td>
            <td>PREPL</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>25</td>
            <td>Aicardi-Goutires Syndrome</td>
            <td>SAMHD1</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>26</td>
            <td>Cystinuria, Type A</td>
            <td>SLC3A1</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>27</td>
            <td>Deafness, autosomal recessive 16</td>
            <td>STRC</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>28</td>
            <td>Usher Syndrome, Type 2A</td>
            <td>USH2A</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>29</td>
            <td>Choreo-acanthocytosis</td>
            <td>VPS13A</td>
            <td>CNV</td>
            
            
        </tr>
        <tr>
            <td>30</td>
            <td>Congenital Adrenal Hyperplasia, 21-hydroxylase-deficient</td>
            <td>CYP21A2</td>
            <td>SC</td>
            
            
        </tr>
        <tr>
            <td>31</td>
            <td>Alpha-Thalassemia</td>
            <td>HBA1</td>
            <td>SC</td>
            
            
        </tr>
        <tr>
            <td>32</td>
            <td>Alpha-Thalassemia</td>
            <td>HBA2</td>
            <td>SC</td>
            
            
        </tr>
        <tr>
            <td>33</td>
            <td>Spinal Muscular Atrophy</td>
            <td>SMN1</td>
            <td>SC</td>
            
            
        </tr>
        <tr>
            <td>34</td>
            <td>Achalasia-Addisonianism-Alacrima Syndrome</td>
            <td>AAAS</td>
            
            
            
        </tr>
        <tr>
            <td>35</td>
            <td>Harlequin ichthyosis</td>
            <td>ABCA12</td>
            
            
            
        </tr>
        <tr>
            <td>36</td>
            <td>Stargardt Disease, Type 1</td>
            <td>ABCA4</td>
            
            
            
        </tr>
        <tr>
            <td>37</td>
            <td>Progressive Familial Intrahepatic Cholestasis, Type 2</td>
            <td>ABCB11</td>
            
            
            
        </tr>
        <tr>
            <td>38</td>
            <td>Progressive Familial Intrahepatic Cholestasis, Type 3</td>
            <td>ABCB4</td>
            
            
            
        </tr>
        <tr>
            <td>39</td>
            <td>Pseudoxanthoma elasticum</td>
            <td>ABCC6</td>
            
            
            
        </tr>
        <tr>
            <td>40</td>
            <td>Familial Hyperinsulinism, ABCC8-Related</td>
            <td>ABCC8</td>
            
            
            
        </tr>
        <tr>
            <td>41</td>
            <td>Adrenoleukodystrophy, X-Linked</td>
            <td>ABCD1</td>
            
            
            
        </tr>
        <tr>
            <td>42</td>
            <td>Mitochondrial Complex I Deficiency, ACAD9-Related</td>
            <td>ACAD9</td>
            
            
            
        </tr>
        <tr>
            <td>43</td>
            <td>Medium Chain Acyl-CoA Dehydrogenase Deficiency</td>
            <td>ACADM</td>
            
            
            
        </tr>
        <tr>
            <td>44</td>
            <td>Short Chain Acyl-CoA Dehydrogenase Deficiency</td>
            <td>ACADS</td>
            
            
            
        </tr>
        <tr>
            <td>45</td>
            <td>Short/branched chain acyl-CoA dehydrogenase</td>
            <td>ACADSB</td>
            
            
            
        </tr>
        <tr>
            <td>46</td>
            <td>Very Long-Chain Acyl-CoA Dehydrogenase Deficiency</td>
            <td>ACADVL</td>
            
            
            
        </tr>
        <tr>
            <td>47</td>
            <td>Beta-Ketothiolase Deficiency</td>
            <td>ACAT1</td>
            
            
            
        </tr>
        <tr>
            <td>48</td>
            <td>Acyl-CoA Oxidase I Deficiency</td>
            <td>ACOX1</td>
            
            
            
        </tr>
        <tr>
            <td>49</td>
            <td>Combined Malonic and Methylmalonic Aciduria</td>
            <td>ACSF3</td>
            
            
            
        </tr>
        <tr>
            <td>50</td>
            <td>Severe Combined Immunodeficiency, ADA-Related</td>
            <td>ADA</td>
            
            
            
        </tr>
        <tr>
            <td>51</td>
            <td>Ehlers-Danlos Syndrome, Type VIIC</td>
            <td>ADAMTS2</td>
            
            
            
        </tr>
        <tr>
            <td>52</td>
            <td>Bilateral Frontoparietal Polymicrogyria</td>
            <td>ADGRG1</td>
            
            
            
        </tr>
        <tr>
            <td>53</td>
            <td>Aspartylglucosaminuria</td>
            <td>AGA</td>
            
            
            
        </tr>
        <tr>
            <td>54</td>
            <td>Glycogen Storage Disease, Type III (Cori/Forbes)</td>
            <td>AGL</td>
            
            
            
        </tr>
        <tr>
            <td>55</td>
            <td>Rhizomelic Chondrodysplasia Punctata, Type 3</td>
            <td>AGPS</td>
            
            
            
        </tr>
        <tr>
            <td>56</td>
            <td>Hyperoxaluria, Primary, Type 1</td>
            <td>AGXT</td>
            
            
            
        </tr>
        <tr>
            <td>57</td>
            <td>Autoimmune polyendocrinopathy syndrome, type I</td>
            <td>AIRE</td>
            
            
            
        </tr>
        <tr>
            <td>58</td>
            <td>Sjogren-Larsson Syndrome</td>
            <td>ALDH3A2</td>
            
            
            
        </tr>
        <tr>
            <td>59</td>
            <td>Pyridoxine-dependent epilepsy</td>
            <td>ALDH7A1</td>
            
            
            
        </tr>
        <tr>
            <td>60</td>
            <td>Hereditary Fructose Intolerance</td>
            <td>ALDOB</td>
            
            
            
        </tr>
        <tr>
            <td>61</td>
            <td>Congenital Disorder of Glycosylation, Type 1C</td>
            <td>ALG6</td>
            
            
            
        </tr>
        <tr>
            <td>62</td>
            <td>Alstrom Syndrome</td>
            <td>ALMS1</td>
            
            
            
        </tr>
        <tr>
            <td>63</td>
            <td>Hypophosphatasia, ALPL-Related</td>
            <td>ALPL</td>
            
            
            
        </tr>
        <tr>
            <td>64</td>
            <td>Persistent Müllerian duct syndrome type 1</td>
            <td>AMH</td>
            
            
            
        </tr>
        <tr>
            <td>65</td>
            <td>Persistent Müllerian duct syndrome type 2</td>
            <td>AMHR2</td>
            
            
            
        </tr>
        <tr>
            <td>66</td>
            <td>Glycine Encephalopathy, AMT-Related</td>
            <td>AMT</td>
            
            
            
        </tr>
        <tr>
            <td>67</td>
            <td>Mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma (MEDNIK)</td>
            <td>AP1S1</td>
            
            
            
        </tr>
        <tr>
            <td>68</td>
            <td>Familial Nephrogenic Diabetes Insipidus, AQP2-Related</td>
            <td>AQP2</td>
            
            
            
        </tr>
        <tr>
            <td>69</td>
            <td>Androgen insensitivity syndrome, X-Linked</td>
            <td>AR</td>
            
            
            
        </tr>
        <tr>
            <td>70</td>
            <td>Argininemia</td>
            <td>ARG1</td>
            
            
            
        </tr>
        <tr>
            <td>71</td>
            <td>Metachromatic Leukodystrophy, ARSA-Related</td>
            <td>ARSA</td>
            
            
            
        </tr>
        <tr>
            <td>72</td>
            <td>Mucopolysaccharidosis, Type VI (Maroteaux-Lamy)</td>
            <td>ARSB</td>
            
            
            
        </tr>
        <tr>
            <td>73</td>
            <td>Argininosuccinate Lyase Deficiency</td>
            <td>ASL</td>
            
            
            
        </tr>
        <tr>
            <td>74</td>
            <td>Asparagine Synthetase Deficiency</td>
            <td>ASNS</td>
            
            
            
        </tr>
        <tr>
            <td>75</td>
            <td>Canavan Disease</td>
            <td>ASPA</td>
            
            
            
        </tr>
        <tr>
            <td>76</td>
            <td>Citrullinemia, Type 1</td>
            <td>ASS1</td>
            
            
            
        </tr>
        <tr>
            <td>77</td>
            <td>Renal Tubular Acidosis and Deafness, ATP6V1B1-Related</td>
            <td>ATP6V1B1</td>
            
            
            
        </tr>
        <tr>
            <td>78</td>
            <td>Menkes Syndrome, X-Linked</td>
            <td>ATP7A</td>
            
            
            
        </tr>
        <tr>
            <td>79</td>
            <td>Wilson Disease</td>
            <td>ATP7B</td>
            
            
            
        </tr>
        <tr>
            <td>80</td>
            <td>Progressive Familial Intrahepatic Cholestasis, Type 1</td>
            <td>ATP8B1</td>
            
            
            
        </tr>
        <tr>
            <td>81</td>
            <td>Alpha-Thalassemia Intellectual Disability Syndrome, X-Linked</td>
            <td>ATRX</td>
            
            
            
        </tr>
        <tr>
            <td>82</td>
            <td>Bardet-Biedl Syndrome 1</td>
            <td>BBS1</td>
            
            
            
        </tr>
        <tr>
            <td>83</td>
            <td>Bardet-Biedl Syndrome 10</td>
            <td>BBS10</td>
            
            
            
        </tr>
        <tr>
            <td>84</td>
            <td>Bardet-Biedl Syndrome 12</td>
            <td>BBS12</td>
            
            
            
        </tr>
        <tr>
            <td>85</td>
            <td>Bardet-Biedl Syndrome 2</td>
            <td>BBS2</td>
            
            
            
        </tr>
        <tr>
            <td>86</td>
            <td>Bardet-Biedl Syndrome 9</td>
            <td>BBS9</td>
            
            
            
        </tr>
        <tr>
            <td>87</td>
            <td>Pseudocholinesterase Deficiency</td>
            <td>BCHE</td>
            
            
            
        </tr>
        <tr>
            <td>88</td>
            <td>Maple Syrup Urine Disease, Type 1A</td>
            <td>BCKDHA</td>
            
            
            
        </tr>
        <tr>
            <td>89</td>
            <td>Maple Syrup Urine Disease, Type 1B</td>
            <td>BCKDHB</td>
            
            
            
        </tr>
        <tr>
            <td>90</td>
            <td>GRACILE Syndrome</td>
            <td>BCS1L</td>
            
            
            
        </tr>
        <tr>
            <td>91</td>
            <td>Bloom Syndrome</td>
            <td>BLM</td>
            
            
            
        </tr>
        <tr>
            <td>92</td>
            <td>Fanconi anemia, Group J</td>
            <td>BRIP1</td>
            
            
            
        </tr>
        <tr>
            <td>93</td>
            <td>Bartter syndrome, Type 4a</td>
            <td>BSND</td>
            
            
            
        </tr>
        <tr>
            <td>94</td>
            <td>Biotinidase Deficiency</td>
            <td>BTD</td>
            
            
            
        </tr>
        <tr>
            <td>95</td>
            <td>Isolated growth hormone deficiency, Type III, X-linked</td>
            <td>BTK</td>
            
            
            
        </tr>
        <tr>
            <td>96</td>
            <td>Desbuquois dysplasia 1</td>
            <td>CANT1</td>
            
            
            
        </tr>
        <tr>
            <td>97</td>
            <td>Limb-Girdle Muscular Dystrophy, Type 2A</td>
            <td>CAPN3</td>
            
            
            
        </tr>
        <tr>
            <td>98</td>
            <td>Catecholaminergic polymorphic ventricular tachycardia</td>
            <td>CASQ2</td>
            
            
            
        </tr>
        <tr>
            <td>99</td>
            <td>Homocystinuria, CBS-Related</td>
            <td>CBS</td>
            
            
            
        </tr>
        <tr>
            <td>100</td>
            <td>Usher Syndrome, Type 1D</td>
            <td>CDH23</td>
            
            
            
        </tr>
        <tr>
            <td>101</td>
            <td>Leber Congenital Amaurosis, Type CEP290</td>
            <td>CEP290</td>
            
            
            
        </tr>
        <tr>
            <td>102</td>
            <td>Retinitis Pigmentosa 26</td>
            <td>CERKL</td>
            
            
            
        </tr>
        <tr>
            <td>103</td>
            <td>Choroideremia, X-Linked</td>
            <td>CHM</td>
            
            
            
        </tr>
        <tr>
            <td>104</td>
            <td>Congenital Myasthenic Syndrome, CHRNE-Related</td>
            <td>CHRNE</td>
            
            
            
        </tr>
        <tr>
            <td>105</td>
            <td>Escobar Syndrome</td>
            <td>CHRNG</td>
            
            
            
        </tr>
        <tr>
            <td>106</td>
            <td>Bare Lymphocyte Syndrome, CIITA-Related</td>
            <td>CIITA</td>
            
            
            
        </tr>
        <tr>
            <td>107</td>
            <td>Ceroid Lipofuscinosis, Neuronal, 5</td>
            <td>CLN5</td>
            
            
            
        </tr>
        <tr>
            <td>108</td>
            <td>Ceroid Lipofuscinosis, Neuronal, 6</td>
            <td>CLN6</td>
            
            
            
        </tr>
        <tr>
            <td>109</td>
            <td>Ceroid Lipofuscinosis, Neuronal, 8 (a.ka. Northern Epilepsy)</td>
            <td>CLN8</td>
            
            
            
        </tr>
        <tr>
            <td>110</td>
            <td>Usher Syndrome, Type 3</td>
            <td>CLRN1</td>
            
            
            
        </tr>
        <tr>
            <td>111</td>
            <td>Achromatopsia, CNGA3-Related</td>
            <td>CNGA3</td>
            
            
            
        </tr>
        <tr>
            <td>112</td>
            <td>Achromatopsia, CNGB3-Related</td>
            <td>CNGB3</td>
            
            
            
        </tr>
        <tr>
            <td>113</td>
            <td>Fibrochondrogenesis type 2</td>
            <td>COL11A2</td>
            
            
            
        </tr>
        <tr>
            <td>114</td>
            <td>Alport Syndrome, COL4A3-Related</td>
            <td>COL4A3</td>
            
            
            
        </tr>
        <tr>
            <td>115</td>
            <td>Alport Syndrome, COL4A4-Related</td>
            <td>COL4A4</td>
            
            
            
        </tr>
        <tr>
            <td>116</td>
            <td>Alport Syndrome, X-Linked</td>
            <td>COL4A5</td>
            
            
            
        </tr>
        <tr>
            <td>117</td>
            <td>Dystrophic Epidermolysis Bullosa, COL7A1-Related</td>
            <td>COL7A1</td>
            
            
            
        </tr>
        <tr>
            <td>118</td>
            <td>Carbamoyl Phosphate Synthetase I Deficiency</td>
            <td>CPS1</td>
            
            
            
        </tr>
        <tr>
            <td>119</td>
            <td>Carnitine Palmitoyltransferase IA Deficiency</td>
            <td>CPT1A</td>
            
            
            
        </tr>
        <tr>
            <td>120</td>
            <td>Carnitine Palmitoyltransferase II Deficiency</td>
            <td>CPT2</td>
            
            
            
        </tr>
        <tr>
            <td>121</td>
            <td>Leber congenital amaurosis 8</td>
            <td>CRB1</td>
            
            
            
        </tr>
        <tr>
            <td>122</td>
            <td>Papillon-Lefevre Syndrome</td>
            <td>CTSC</td>
            
            
            
        </tr>
        <tr>
            <td>123</td>
            <td>Ceroid Lipofuscinosis, Neuronal, 10 (CLN10 Disease)</td>
            <td>CTSD</td>
            
            
            
        </tr>
        <tr>
            <td>124</td>
            <td>Pycnodysostosis</td>
            <td>CTSK</td>
            
            
            
        </tr>
        <tr>
            <td>125</td>
            <td>Chronic Granulomatous Disease, CYBA-Related</td>
            <td>CYBA</td>
            
            
            
        </tr>
        <tr>
            <td>126</td>
            <td>Chronic Granulomatous Disease, X-Linked</td>
            <td>CYBB</td>
            
            
            
        </tr>
        <tr>
            <td>127</td>
            <td>Congenital Adrenal Hyperplasia, 11-beta-hydroxylase-deficient</td>
            <td>CYP11B1</td>
            
            
            
        </tr>
        <tr>
            <td>128</td>
            <td>Corticosterone Methyloxidase Deficiency</td>
            <td>CYP11B2</td>
            
            
            
        </tr>
        <tr>
            <td>129</td>
            <td>Congenital Adrenal Hyperplasia, 17-Alpha-Hydroxylase Deficiency</td>
            <td>CYP17A1</td>
            
            
            
        </tr>
        <tr>
            <td>130</td>
            <td>Aromatase Deficiency</td>
            <td>CYP19A1</td>
            
            
            
        </tr>
        <tr>
            <td>131</td>
            <td>Primary Congenital Glaucoma</td>
            <td>CYP1B1</td>
            
            
            
        </tr>
        <tr>
            <td>132</td>
            <td>Cerebrotendinous Xanthomatosis</td>
            <td>CYP27A1</td>
            
            
            
        </tr>
        <tr>
            <td>133</td>
            <td>Vitamin D-dependent rickets type 1A</td>
            <td>CYP27B1</td>
            
            
            
        </tr>
        <tr>
            <td>134</td>
            <td>Maple Syrup Urine Disease, Type 2</td>
            <td>DBT</td>
            
            
            
        </tr>
        <tr>
            <td>135</td>
            <td>Severe Combined Immunodeficiency, Type Athabaskan</td>
            <td>DCLRE1C</td>
            
            
            
        </tr>
        <tr>
            <td>136</td>
            <td>Xeroderma Pigmentosum Group E</td>
            <td>DDB2</td>
            
            
            
        </tr>
        <tr>
            <td>137</td>
            <td>Smith-Lemli-Opitz Syndrome</td>
            <td>DHCR7</td>
            
            
            
        </tr>
        <tr>
            <td>138</td>
            <td>Retinitis Pigmentosa 59</td>
            <td>DHDDS</td>
            
            
            
        </tr>
        <tr>
            <td>139</td>
            <td>Dyskeratosis congenita, X-Linked</td>
            <td>DKC1</td>
            
            
            
        </tr>
        <tr>
            <td>140</td>
            <td>Dihydrolipoamide Dehydrogenase Deficiency</td>
            <td>DLD</td>
            
            
            
        </tr>
        <tr>
            <td>141</td>
            <td>Ciliary Dyskinesia, Primary 3</td>
            <td>DNAH5</td>
            
            
            
        </tr>
        <tr>
            <td>142</td>
            <td>Ciliary Dyskinesia, Primary 1</td>
            <td>DNAI1</td>
            
            
            
        </tr>
        <tr>
            <td>143</td>
            <td>Ciliary Dyskinesia, Primary 9</td>
            <td>DNAI2</td>
            
            
            
        </tr>
        <tr>
            <td>144</td>
            <td>Ciliary Dyskinesia, Primary, 16</td>
            <td>DNAL1</td>
            
            
            
        </tr>
        <tr>
            <td>145</td>
            <td>Congenital Myasthenic Syndrome, DOK7-Related</td>
            <td>DOK7</td>
            
            
            
        </tr>
        <tr>
            <td>146</td>
            <td>Dihydropyrimidine Dehydrogenase Deficiency</td>
            <td>DPYD</td>
            
            
            
        </tr>
        <tr>
            <td>147</td>
            <td>Limb-Girdle Muscular Dystrophy, Type 2B</td>
            <td>DYSF</td>
            
            
            
        </tr>
        <tr>
            <td>148</td>
            <td>Hypohidrotic Ectodermal Dysplasia, X-Linked</td>
            <td>EDA</td>
            
            
            
        </tr>
        <tr>
            <td>149</td>
            <td>Hypohidrotic Ectodermal Dysplasia</td>
            <td>EDAR</td>
            
            
            
        </tr>
        <tr>
            <td>150</td>
            <td>Wolcott-Rallison Syndrome</td>
            <td>EIF2AK3</td>
            
            
            
        </tr>
        <tr>
            <td>151</td>
            <td>Leukoencephalopathy with Vanishing White Matter</td>
            <td>EIF2B5</td>
            
            
            
        </tr>
        <tr>
            <td>152</td>
            <td>Dysautonomia, familial (IKBKAP or ELP1)</td>
            <td>IKBKAP</td>
            
            
            
        </tr>
        <tr>
            <td>153</td>
            <td>Emery-Dreifuss Muscular Dystrophy 1, X-Linked</td>
            <td>EMD</td>
            
            
            
        </tr>
        <tr>
            <td>154</td>
            <td>Xeroderma Pigmentosum Group D</td>
            <td>ERCC2</td>
            
            
            
        </tr>
        <tr>
            <td>155</td>
            <td>Xeroderma Pigmentosum Group B</td>
            <td>ERCC3</td>
            
            
            
        </tr>
        <tr>
            <td>156</td>
            <td>Xeroderma Pigmentosum Group F</td>
            <td>ERCC4</td>
            
            
            
        </tr>
        <tr>
            <td>157</td>
            <td>Xeroderma pigmentosum Group G</td>
            <td>ERCC5</td>
            
            
            
        </tr>
        <tr>
            <td>158</td>
            <td>Cockayne syndrome, type B</td>
            <td>ERCC6</td>
            
            
            
        </tr>
        <tr>
            <td>159</td>
            <td>Cockayne syndrome, type A</td>
            <td>ERCC8</td>
            
            
            
        </tr>
        <tr>
            <td>160</td>
            <td>Roberts Syndrome</td>
            <td>ESCO2</td>
            
            
            
        </tr>
        <tr>
            <td>161</td>
            <td>Glutaric Acidemia, Type 2A</td>
            <td>ETFA</td>
            
            
            
        </tr>
        <tr>
            <td>162</td>
            <td>Glutaric Acidemia, Type 2B</td>
            <td>ETFB</td>
            
            
            
        </tr>
        <tr>
            <td>163</td>
            <td>Glutaric Acidemia, Type 2C</td>
            <td>ETFDH</td>
            
            
            
        </tr>
        <tr>
            <td>164</td>
            <td>Ethylmalonic Encephalopathy</td>
            <td>ETHE1</td>
            
            
            
        </tr>
        <tr>
            <td>165</td>
            <td>Ellis-van Creveld Syndrome, EVC-Related</td>
            <td>EVC</td>
            
            
            
        </tr>
        <tr>
            <td>166</td>
            <td>Ellis-van Creveld Syndrome, EVC2-related</td>
            <td>EVC2</td>
            
            
            
        </tr>
        <tr>
            <td>167</td>
            <td>Pontocerebellar Hypoplasia, Type 1B</td>
            <td>EXOSC3</td>
            
            
            
        </tr>
        <tr>
            <td>168</td>
            <td>Retinitis Pigmentosa 25</td>
            <td>EYS</td>
            
            
            
        </tr>
        <tr>
            <td>169</td>
            <td>Factor XI deficiency</td>
            <td>F11</td>
            
            
            
        </tr>
        <tr>
            <td>170</td>
            <td>Prothrombin deficiency</td>
            <td>F2</td>
            
            
            
        </tr>
        <tr>
            <td>171</td>
            <td>Hemophilia A</td>
            <td>F8</td>
            
            
            
        </tr>
        <tr>
            <td>172</td>
            <td>Hemophilia B</td>
            <td>F9</td>
            
            
            
        </tr>
        <tr>
            <td>173</td>
            <td>Tyrosinemia, Type I</td>
            <td>FAH</td>
            
            
            
        </tr>
        <tr>
            <td>174</td>
            <td>Retinitis Pigmentosa 28</td>
            <td>FAM161A</td>
            
            
            
        </tr>
        <tr>
            <td>175</td>
            <td>Fanconi Anemia, Group G</td>
            <td>FANCG</td>
            
            
            
        </tr>
        <tr>
            <td>176</td>
            <td>Fumarase Deficiency</td>
            <td>FH</td>
            
            
            
        </tr>
        <tr>
            <td>177</td>
            <td>Limb-Girdle Muscular Dystrophy, Type 2I</td>
            <td>FKRP</td>
            
            
            
        </tr>
        <tr>
            <td>178</td>
            <td>Walker-Warburg Syndrome, FKTN-Related</td>
            <td>FKTN</td>
            
            
            
        </tr>
        <tr>
            <td>179</td>
            <td>Glycogen Storage Disease, Type IA</td>
            <td>G6PC</td>
            
            
            
        </tr>
        <tr>
            <td>180</td>
            <td>Glucose-6-Phosphate Dehydrogenase Deficiency*</td>
            <td>G6PD</td>
            
            
            
        </tr>
        <tr>
            <td>181</td>
            <td>Galactose epimerase deficiency</td>
            <td>GALE</td>
            
            
            
        </tr>
        <tr>
            <td>182</td>
            <td>Galactokinase Deficiency (Galactosemia, Type II)</td>
            <td>GALK1</td>
            
            
            
        </tr>
        <tr>
            <td>183</td>
            <td>Mucopolysaccharidosis, Type IVA</td>
            <td>GALNS</td>
            
            
            
        </tr>
        <tr>
            <td>184</td>
            <td>Hyperphosphatemic familial tumoral calcinosis</td>
            <td>GALNT3</td>
            
            
            
        </tr>
        <tr>
            <td>185</td>
            <td>Guanidinoacetate Methyltransferase Deficiency</td>
            <td>GAMT</td>
            
            
            
        </tr>
        <tr>
            <td>186</td>
            <td>Gaucher Disease</td>
            <td>GBA</td>
            
            
            
        </tr>
        <tr>
            <td>187</td>
            <td>Glycogen Storage Disease, Type IV</td>
            <td>GBE1</td>
            
            
            
        </tr>
        <tr>
            <td>188</td>
            <td>Glutaric Acidemia, Type 1</td>
            <td>GCDH</td>
            
            
            
        </tr>
        <tr>
            <td>189</td>
            <td>Dopa-responsive dystonia</td>
            <td>GCH1</td>
            
            
            
        </tr>
        <tr>
            <td>190</td>
            <td>Grebe syndrome</td>
            <td>GDF5</td>
            
            
            
        </tr>
        <tr>
            <td>191</td>
            <td>Combined Oxidative Phosphorylation Deficiency 1</td>
            <td>GFM1</td>
            
            
            
        </tr>
        <tr>
            <td>192</td>
            <td>Isolated growth hormone deficiency, Type IB</td>
            <td>GHRHR</td>
            
            
            
        </tr>
        <tr>
            <td>193</td>
            <td>Charcot-Marie-Tooth Disease with Deafness, X-Linked</td>
            <td>GJB1</td>
            
            
            
        </tr>
        <tr>
            <td>194</td>
            <td>Erythrokeratodermia variabilis et progressiva</td>
            <td>GJB3</td>
            
            
            
        </tr>
        <tr>
            <td>195</td>
            <td>Mucopolysaccharidosis, Type IVB / GM1 Gangliosidosis</td>
            <td>GLB1</td>
            
            
            
        </tr>
        <tr>
            <td>196</td>
            <td>Glycine Encephalopathy, GLDC-Related</td>
            <td>GLDC</td>
            
            
            
        </tr>
        <tr>
            <td>197</td>
            <td>Lethal Congenital Contracture Syndrome 1</td>
            <td>GLE1</td>
            
            
            
        </tr>
        <tr>
            <td>198</td>
            <td>Inclusion Body Myopathy 2</td>
            <td>GNE</td>
            
            
            
        </tr>
        <tr>
            <td>199</td>
            <td>Mucolipidosis II/IIIA</td>
            <td>GNPTAB</td>
            
            
            
        </tr>
        <tr>
            <td>200</td>
            <td>Mucolipidosis III gamma</td>
            <td>GNPTG</td>
            
            
            
        </tr>
        <tr>
            <td>201</td>
            <td>Mucopolysaccharidosis, Type IIID (Sanfilippo D)</td>
            <td>GNS</td>
            
            
            
        </tr>
        <tr>
            <td>202</td>
            <td>Geroderma osteodysplastica</td>
            <td>GORAB</td>
            
            
            
        </tr>
        <tr>
            <td>203</td>
            <td>Bernard-Soulier Syndrome, Type A2</td>
            <td>GP1BA</td>
            
            
            
        </tr>
        <tr>
            <td>204</td>
            <td>Bernard-Soulier Syndrome, Type B</td>
            <td>GP1BB</td>
            
            
            
        </tr>
        <tr>
            <td>205</td>
            <td>Bernard-Soulier Syndrome, Type C</td>
            <td>GP9</td>
            
            
            
        </tr>
        <tr>
            <td>206</td>
            <td>Primary Hyperoxaluria, Type 2</td>
            <td>GRHPR</td>
            
            
            
        </tr>
        <tr>
            <td>207</td>
            <td>Leber congenital amaurosis 1</td>
            <td>GUCY2D</td>
            
            
            
        </tr>
        <tr>
            <td>208</td>
            <td>Mucopolysaccharidosis, Type VII</td>
            <td>GUSB</td>
            
            
            
        </tr>
        <tr>
            <td>209</td>
            <td>Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency</td>
            <td>HADHA</td>
            
            
            
        </tr>
        <tr>
            <td>210</td>
            <td>Trifunctional protein deficiency</td>
            <td>HADHB</td>
            
            
            
        </tr>
        <tr>
            <td>211</td>
            <td>Congenital Neutropenia, HAX1-Related</td>
            <td>HAX1</td>
            
            
            
        </tr>
        <tr>
            <td>212</td>
            <td>Sandhoff Disease</td>
            <td>HEXB</td>
            
            
            
        </tr>
        <tr>
            <td>213</td>
            <td>Hemochromatosis, Type 1</td>
            <td>HFE</td>
            
            
            
        </tr>
        <tr>
            <td>214</td>
            <td>Hemochromatosis, Type 2A</td>
            <td>HFE2</td>
            
            
            
        </tr>
        <tr>
            <td>215</td>
            <td>Alkaptonuria</td>
            <td>HGD</td>
            
            
            
        </tr>
        <tr>
            <td>216</td>
            <td>Mucopolysaccharidosis, Type IIIC (Sanfilippo C)</td>
            <td>HGSNAT</td>
            
            
            
        </tr>
        <tr>
            <td>217</td>
            <td>Holocarboxylase Synthetase Deficiency</td>
            <td>HLCS</td>
            
            
            
        </tr>
        <tr>
            <td>218</td>
            <td>3-Hydroxy-3-Methylglutaryl-Coenzyme A Lyase Deficiency</td>
            <td>HMGCL</td>
            
            
            
        </tr>
        <tr>
            <td>219</td>
            <td>Heme Oxygenase-1 Deficiency</td>
            <td>HMOX1</td>
            
            
            
        </tr>
        <tr>
            <td>220</td>
            <td>Primary Hyperoxaluria, Type 3</td>
            <td>HOGA1</td>
            
            
            
        </tr>
        <tr>
            <td>221</td>
            <td>Tyrosinemia, Type III</td>
            <td>HPD</td>
            
            
            
        </tr>
        <tr>
            <td>222</td>
            <td>Hermansky-Pudlak Syndrome 1</td>
            <td>HPS1</td>
            
            
            
        </tr>
        <tr>
            <td>223</td>
            <td>Hermansky-Pudlak Syndrome 3</td>
            <td>HPS3</td>
            
            
            
        </tr>
        <tr>
            <td>224</td>
            <td>Hermansky-Pudlak syndrome 4</td>
            <td>HPS4</td>
            
            
            
        </tr>
        <tr>
            <td>225</td>
            <td>17-beta hydroxysteroid dehydrogenase 3 deficiency</td>
            <td>HSD17B3</td>
            
            
            
        </tr>
        <tr>
            <td>226</td>
            <td>D-Bifunctional Protein Deficiency</td>
            <td>HSD17B4</td>
            
            
            
        </tr>
        <tr>
            <td>227</td>
            <td>3-Beta-Hydroxysteroid Dehydrogenase Type II Deficiency</td>
            <td>HSD3B2</td>
            
            
            
        </tr>
        <tr>
            <td>228</td>
            <td>Hydrolethalus Syndrome</td>
            <td>HYLS1</td>
            
            
            
        </tr>
        <tr>
            <td>229</td>
            <td>Mucopolysaccharidosis, Type II (Hunter Syndrome)</td>
            <td>IDS</td>
            
            
            
        </tr>
        <tr>
            <td>230</td>
            <td>Mucopolysaccharidosis, Type I (Hurler Syndrome)</td>
            <td>IDUA</td>
            
            
            
        </tr>
        <tr>
            <td>231</td>
            <td>Severe Combined Immunodeficiency, X-Linked</td>
            <td>IL2RG</td>
            
            
            
        </tr>
        <tr>
            <td>232</td>
            <td>Isovaleric Acidemia</td>
            <td>IVD</td>
            
            
            
        </tr>
        <tr>
            <td>233</td>
            <td>Congenital Hyperinsulinism, KCNJ11-Related</td>
            <td>KCNJ11</td>
            
            
            
        </tr>
        <tr>
            <td>234</td>
            <td>LAMA2-related Muscular Dystrophy</td>
            <td>LAMA2</td>
            
            
            
        </tr>
        <tr>
            <td>235</td>
            <td>Herlitz Junctional Epidermolysis Bullosa, LAMA3-Related</td>
            <td>LAMA3</td>
            
            
            
        </tr>
        <tr>
            <td>236</td>
            <td>Herlitz Junctional Epidermolysis Bullosa, LAMB3-Related</td>
            <td>LAMB3</td>
            
            
            
        </tr>
        <tr>
            <td>237</td>
            <td>Herlitz Junctional Epidermolysis Bullosa, LAMC2-Related</td>
            <td>LAMC2</td>
            
            
            
        </tr>
        <tr>
            <td>238</td>
            <td>Leber Congenital Amaurosis, Type LCA5</td>
            <td>LCA5</td>
            
            
            
        </tr>
        <tr>
            <td>239</td>
            <td>Familial Hypercholesterolemia, LDLR-Related</td>
            <td>LDLR</td>
            
            
            
        </tr>
        <tr>
            <td>240</td>
            <td>Familial Hypercholesterolemia, LDLRAP1-Related</td>
            <td>LDLRAP1</td>
            
            
            
        </tr>
        <tr>
            <td>241</td>
            <td>Leydig cell hypoplasia</td>
            <td>LHCGR</td>
            
            
            
        </tr>
        <tr>
            <td>242</td>
            <td>Stuve-Wiedemann Syndrome</td>
            <td>LIFR</td>
            
            
            
        </tr>
        <tr>
            <td>243</td>
            <td>Lysosomal Acid Lipase Deficiency</td>
            <td>LIPA</td>
            
            
            
        </tr>
        <tr>
            <td>244</td>
            <td>Woolly Hair/Hypotrichosis Syndrome</td>
            <td>LIPH</td>
            
            
            
        </tr>
        <tr>
            <td>245</td>
            <td>Deafness, Autosomal Recessive 77</td>
            <td>LOXHD1</td>
            
            
            
        </tr>
        <tr>
            <td>246</td>
            <td>Lipoprotein Lipase Deficiency</td>
            <td>LPL</td>
            
            
            
        </tr>
        <tr>
            <td>247</td>
            <td>Leigh Syndrome, French-Canadian Type</td>
            <td>LRPPRC</td>
            
            
            
        </tr>
        <tr>
            <td>248</td>
            <td>Chediak-Higashi syndrome</td>
            <td>LYST</td>
            
            
            
        </tr>
        <tr>
            <td>249</td>
            <td>Alpha-Mannosidosis</td>
            <td>MAN2B1</td>
            
            
            
        </tr>
        <tr>
            <td>250</td>
            <td>Hypermethioninemia</td>
            <td>MAT1A</td>
            
            
            
        </tr>
        <tr>
            <td>251</td>
            <td>3-Methylcrotonyl-CoA Carboxylase 1 Deficiency</td>
            <td>MCCC1</td>
            
            
            
        </tr>
        <tr>
            <td>252</td>
            <td>3-Methylcrotonyl-CoA Carboxylase 2 Deficiency</td>
            <td>MCCC2</td>
            
            
            
        </tr>
        <tr>
            <td>253</td>
            <td>RETT Syndrome</td>
            <td>MECP2</td>
            
            
            
        </tr>
        <tr>
            <td>254</td>
            <td>Microcephaly, postnatal progressive, with seizures and brain atrophy</td>
            <td>MED17</td>
            
            
            
        </tr>
        <tr>
            <td>255</td>
            <td>Familial Mediterranean Fever</td>
            <td>MEFV</td>
            
            
            
        </tr>
        <tr>
            <td>256</td>
            <td>Spondylothoracic Dysostosis, MESP2-Related</td>
            <td>MESP2</td>
            
            
            
        </tr>
        <tr>
            <td>257</td>
            <td>Ceroid Lipofuscinosis, Neuronal, 7</td>
            <td>MFSD8</td>
            
            
            
        </tr>
        <tr>
            <td>258</td>
            <td>Bardet-Biedl Syndrome 6</td>
            <td>MKKS</td>
            
            
            
        </tr>
        <tr>
            <td>259</td>
            <td>Meckel-Gruber Syndrome, Type 1</td>
            <td>MKS1</td>
            
            
            
        </tr>
        <tr>
            <td>260</td>
            <td>Megalencephalic Leukoencephalopathy with Subcortical Cysts</td>
            <td>MLC1</td>
            
            
            
        </tr>
        <tr>
            <td>261</td>
            <td>Malonyl-CoA decarboxylase deficiency</td>
            <td>MLYCD</td>
            
            
            
        </tr>
        <tr>
            <td>262</td>
            <td>Methylmalonic Aciduria, MMAA-Related</td>
            <td>MMAA</td>
            
            
            
        </tr>
        <tr>
            <td>263</td>
            <td>Methylmalonic Aciduria, MMAB-Related</td>
            <td>MMAB</td>
            
            
            
        </tr>
        <tr>
            <td>264</td>
            <td>Methylmalonic Aciduria and Homocystinuria, Type cblC</td>
            <td>MMACHC</td>
            
            
            
        </tr>
        <tr>
            <td>265</td>
            <td>Methylmalonic Aciduria and Homocystinuria, Type cblD</td>
            <td>MMADHC</td>
            
            
            
        </tr>
        <tr>
            <td>266</td>
            <td>Molybdenum cofactor deficiency</td>
            <td>MOCS1</td>
            
            
            
        </tr>
        <tr>
            <td>267</td>
            <td>Congenital Disorder of Glycosylation, Type 1B</td>
            <td>MPI</td>
            
            
            
        </tr>
        <tr>
            <td>268</td>
            <td>Congenital Amegakaryocytic Thrombocytopenia</td>
            <td>MPL</td>
            
            
            
        </tr>
        <tr>
            <td>269</td>
            <td>Hepatocerebral Mitochondrial DNA Depletion Syndrome, MPV17-Related</td>
            <td>MPV17</td>
            
            
            
        </tr>
        <tr>
            <td>270</td>
            <td>Ataxia-telangiectasia-like disorder 1</td>
            <td>MRE11</td>
            
            
            
        </tr>
        <tr>
            <td>271</td>
            <td>Homocystinuria due to Deficiency of MTHFR</td>
            <td>MTHFR</td>
            
            
            
        </tr>
        <tr>
            <td>272</td>
            <td>Myotubular Myopathy, X-Linked</td>
            <td>MTM1</td>
            
            
            
        </tr>
        <tr>
            <td>273</td>
            <td>Homocystinuria, Type cblE</td>
            <td>MTRR</td>
            
            
            
        </tr>
        <tr>
            <td>274</td>
            <td>Abetalipoproteinemia</td>
            <td>MTTP</td>
            
            
            
        </tr>
        <tr>
            <td>275</td>
            <td>Methylmalonic Aciduria, Type mut(0)</td>
            <td>MUT</td>
            
            
            
        </tr>
        <tr>
            <td>276</td>
            <td>Deafness, autosomal recessive, 3</td>
            <td>MYO15A</td>
            
            
            
        </tr>
        <tr>
            <td>277</td>
            <td>Usher Syndrome, Type 1B</td>
            <td>MYO7A</td>
            
            
            
        </tr>
        <tr>
            <td>278</td>
            <td>Mucopolysaccharidosis, Type IIIB (Sanfilippo B)</td>
            <td>NAGLU</td>
            
            
            
        </tr>
        <tr>
            <td>279</td>
            <td>N-acetylglutamate Synthase Deficiency</td>
            <td>NAGS</td>
            
            
            
        </tr>
        <tr>
            <td>280</td>
            <td>Nijmegen Breakage Syndrome</td>
            <td>NBN</td>
            
            
            
        </tr>
        <tr>
            <td>281</td>
            <td>Charcot-Marie-Tooth Disease type 4D</td>
            <td>NDRG1</td>
            
            
            
        </tr>
        <tr>
            <td>282</td>
            <td>Mitochondrial Complex I Deficiency, NDUFAF5-Related</td>
            <td>NDUFAF5</td>
            
            
            
        </tr>
        <tr>
            <td>283</td>
            <td>Mitochondrial complex I deficiency</td>
            <td>NDUFS4</td>
            
            
            
        </tr>
        <tr>
            <td>284</td>
            <td>Mitochondrial Complex I Deficiency, NDUFS6-Related</td>
            <td>NDUFS6</td>
            
            
            
        </tr>
        <tr>
            <td>285</td>
            <td>Sialidosis</td>
            <td>NEU1</td>
            
            
            
        </tr>
        <tr>
            <td>286</td>
            <td>Hydatidiform Mole, Recurrent</td>
            <td>NLRP7</td>
            
            
            
        </tr>
        <tr>
            <td>287</td>
            <td>Niemann-Pick Disease, Type C1/D</td>
            <td>NPC1</td>
            
            
            
        </tr>
        <tr>
            <td>288</td>
            <td>Niemann-Pick Disease, Type C2</td>
            <td>NPC2</td>
            
            
            
        </tr>
        <tr>
            <td>289</td>
            <td>Juvenile Nephronophthisis</td>
            <td>NPHP1</td>
            
            
            
        </tr>
        <tr>
            <td>290</td>
            <td>Congenital Finnish Nephrosis</td>
            <td>NPHS1</td>
            
            
            
        </tr>
        <tr>
            <td>291</td>
            <td>Steroid-Resistant Nephrotic Syndrome</td>
            <td>NPHS2</td>
            
            
            
        </tr>
        <tr>
            <td>292</td>
            <td>Congenital Adrenal Hypoplasia, X-linked</td>
            <td>NR0B1</td>
            
            
            
        </tr>
        <tr>
            <td>293</td>
            <td>Enhanced S-Cone Syndrome</td>
            <td>NR2E3</td>
            
            
            
        </tr>
        <tr>
            <td>294</td>
            <td>Congenital Insensitivity to Pain with Anhidrosis (CIPA)</td>
            <td>NTRK1</td>
            
            
            
        </tr>
        <tr>
            <td>295</td>
            <td>Ornithine Aminotransferase Deficiency</td>
            <td>OAT</td>
            
            
            
        </tr>
        <tr>
            <td>296</td>
            <td>Lowe syndrome, X-Linked</td>
            <td>OCRL</td>
            
            
            
        </tr>
        <tr>
            <td>297</td>
            <td>Costeff Syndrome (3-Methylglutaconic Aciduria, Type 3)</td>
            <td>OPA3</td>
            
            
            
        </tr>
        <tr>
            <td>298</td>
            <td>Ornithine Transcarbamylase Deficiency</td>
            <td>OTC</td>
            
            
            
        </tr>
        <tr>
            <td>299</td>
            <td>Pantothenate Kinase-Associated Neurodegeneration</td>
            <td>PANK2</td>
            
            
            
        </tr>
        <tr>
            <td>300</td>
            <td>Pyruvate Carboxylase Deficiency</td>
            <td>PC</td>
            
            
            
        </tr>
        <tr>
            <td>301</td>
            <td>Propionic Acidemia, PCCA-Related</td>
            <td>PCCA</td>
            
            
            
        </tr>
        <tr>
            <td>302</td>
            <td>Propionic Acidemia, PCCB-Related</td>
            <td>PCCB</td>
            
            
            
        </tr>
        <tr>
            <td>303</td>
            <td>Pyruvate Dehydrogenase Deficiency, X-Linked</td>
            <td>PDHA1</td>
            
            
            
        </tr>
        <tr>
            <td>304</td>
            <td>Pyruvate Dehydrogenase Deficiency, PDHB-Related</td>
            <td>PDHB</td>
            
            
            
        </tr>
        <tr>
            <td>305</td>
            <td>Prolidase deficiency</td>
            <td>PEPD</td>
            
            
            
        </tr>
        <tr>
            <td>306</td>
            <td>Cytochrome-c oxidase deficiency</td>
            <td>PET100</td>
            
            
            
        </tr>
        <tr>
            <td>307</td>
            <td>Peroxisome Biogenesis Disorder 1A (Zellweger)</td>
            <td>PEX1</td>
            
            
            
        </tr>
        <tr>
            <td>308</td>
            <td>Peroxisome Biogenesis Disorder 6A (Zellweger)</td>
            <td>PEX10</td>
            
            
            
        </tr>
        <tr>
            <td>309</td>
            <td>Peroxisome Biogenesis Disorder 3A (Zellweger)</td>
            <td>PEX12</td>
            
            
            
        </tr>
        <tr>
            <td>310</td>
            <td>Peroxisome Biogenesis Disorder 5A (Zellweger)</td>
            <td>PEX2</td>
            
            
            
        </tr>
        <tr>
            <td>311</td>
            <td>Peroxisome Biogenesis Disorder 4A (Zellweger)</td>
            <td>PEX6</td>
            
            
            
        </tr>
        <tr>
            <td>312</td>
            <td>Rhizomelic Chondrodysplasia Punctata, Type 1</td>
            <td>PEX7</td>
            
            
            
        </tr>
        <tr>
            <td>313</td>
            <td>Glycogen Storage Disease, Type VII</td>
            <td>PFKM</td>
            
            
            
        </tr>
        <tr>
            <td>314</td>
            <td>Phosphoglycerate Dehydrogenase Deficiency</td>
            <td>PHGDH</td>
            
            
            
        </tr>
        <tr>
            <td>315</td>
            <td>Multiple congenital anomalies-hypotonia-seizures syndrome 1</td>
            <td>PIGN</td>
            
            
            
        </tr>
        <tr>
            <td>316</td>
            <td>Polycystic Kidney Disease, Autosomal Recessive</td>
            <td>PKHD1</td>
            
            
            
        </tr>
        <tr>
            <td>317</td>
            <td>Infantile neuroaxonal dystrophy 1</td>
            <td>PLA2G6</td>
            
            
            
        </tr>
        <tr>
            <td>318</td>
            <td>Congenital Disorder of Glycosylation, Type 1A, PMM2-Related</td>
            <td>PMM2</td>
            
            
            
        </tr>
        <tr>
            <td>319</td>
            <td>Pyridoxal 5&#39;-phosphate-dependent epilepsy</td>
            <td>PNPO</td>
            
            
            
        </tr>
        <tr>
            <td>320</td>
            <td>POLG-Related Disorders</td>
            <td>POLG</td>
            
            
            
        </tr>
        <tr>
            <td>321</td>
            <td>Xeroderma pigmentosum Variant</td>
            <td>POLH</td>
            
            
            
        </tr>
        <tr>
            <td>322</td>
            <td>Muscle-Eye-Brain Disease, POMGNT1-Related</td>
            <td>POMGNT1</td>
            
            
            
        </tr>
        <tr>
            <td>323</td>
            <td>Cytochrome P450 oxidoreductase deficiency</td>
            <td>POR</td>
            
            
            
        </tr>
        <tr>
            <td>324</td>
            <td>Ceroid Lipofuscinosis, Neuronal, 1</td>
            <td>PPT1</td>
            
            
            
        </tr>
        <tr>
            <td>325</td>
            <td>Combined Pituitary Hormone Deficiency 2</td>
            <td>PROP1</td>
            
            
            
        </tr>
        <tr>
            <td>326</td>
            <td>Arts syndrome, X-Linked</td>
            <td>PRPS1</td>
            
            
            
        </tr>
        <tr>
            <td>327</td>
            <td>Metachromatic Leukodystrophy, PSAP-Related</td>
            <td>PSAP</td>
            
            
            
        </tr>
        <tr>
            <td>328</td>
            <td>6-Pyruvoyl-Tetrahydropterin Synthase (PTPS) Deficiency</td>
            <td>PTS</td>
            
            
            
        </tr>
        <tr>
            <td>329</td>
            <td>Mitochondrial Myopathy and Sideroblastic Anemia (MLASA1)</td>
            <td>PUS1</td>
            
            
            
        </tr>
        <tr>
            <td>330</td>
            <td>Glycogen Storage Disease, Type V (McArdle Disease)</td>
            <td>PYGM</td>
            
            
            
        </tr>
        <tr>
            <td>331</td>
            <td>Carpenter Syndrome</td>
            <td>RAB23</td>
            
            
            
        </tr>
        <tr>
            <td>332</td>
            <td>Omenn Syndrome, RAG1-Related</td>
            <td>RAG1</td>
            
            
            
        </tr>
        <tr>
            <td>333</td>
            <td>Omenn Syndrome, RAG2-Related</td>
            <td>RAG2</td>
            
            
            
        </tr>
        <tr>
            <td>334</td>
            <td>Congenital Myasthenic Syndrome, RAPSN-Related</td>
            <td>RAPSN</td>
            
            
            
        </tr>
        <tr>
            <td>335</td>
            <td>Pontocerebellar Hypoplasia, Type 1 and 6, RARS2-Related</td>
            <td>RARS2</td>
            
            
            
        </tr>
        <tr>
            <td>336</td>
            <td>Leber Congenital Amaurosis, Type RDH12</td>
            <td>RDH12</td>
            
            
            
        </tr>
        <tr>
            <td>337</td>
            <td>Retinal Dystrophies, RLBP1-Associated</td>
            <td>RLBP1</td>
            
            
            
        </tr>
        <tr>
            <td>338</td>
            <td>Cartilage-Hair Hypoplasia</td>
            <td>RMRP</td>
            
            
            
        </tr>
        <tr>
            <td>339</td>
            <td>Aicardi-Goutieres syndrome, RNASEH2C-related</td>
            <td>RNASEH2C</td>
            
            
            
        </tr>
        <tr>
            <td>340</td>
            <td>Leber Congenital Amaurosis 2</td>
            <td>RPE65</td>
            
            
            
        </tr>
        <tr>
            <td>341</td>
            <td>Ciliopathies, RPGRIP1L-Related</td>
            <td>RPGRIP1L</td>
            
            
            
        </tr>
        <tr>
            <td>342</td>
            <td>Juvenile Retinoschisis, X-Linked</td>
            <td>RS1</td>
            
            
            
        </tr>
        <tr>
            <td>343</td>
            <td>Dyskeratosis Congenita, RTEL1-Related</td>
            <td>RTEL1</td>
            
            
            
        </tr>
        <tr>
            <td>344</td>
            <td>Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay</td>
            <td>SACS</td>
            
            
            
        </tr>
        <tr>
            <td>345</td>
            <td>MIRAGE syndrome</td>
            <td>SAMD9</td>
            
            
            
        </tr>
        <tr>
            <td>346</td>
            <td>Shwachman-Diamond syndrome</td>
            <td>SBDS</td>
            
            
            
        </tr>
        <tr>
            <td>347</td>
            <td>Pontocerebellar Hypoplasia, Type 2D</td>
            <td>SEPSECS</td>
            
            
            
        </tr>
        <tr>
            <td>348</td>
            <td>Alpha-1-Antitrypsin Deficiency</td>
            <td>SERPINA1</td>
            
            
            
        </tr>
        <tr>
            <td>349</td>
            <td>Limb-Girdle Muscular Dystrophy, Type 2D</td>
            <td>SGCA</td>
            
            
            
        </tr>
        <tr>
            <td>350</td>
            <td>Limb-Girdle Muscular Dystrophy, Type 2E</td>
            <td>SGCB</td>
            
            
            
        </tr>
        <tr>
            <td>351</td>
            <td>Limb-Girdle Muscular Dystrophy, Type 2F</td>
            <td>SGCD</td>
            
            
            
        </tr>
        <tr>
            <td>352</td>
            <td>Limb-Girdle Muscular Dystrophy, Type 2C</td>
            <td>SGCG</td>
            
            
            
        </tr>
        <tr>
            <td>353</td>
            <td>Mucopolysaccharidosis, Type IIIA (Sanfilippo A)</td>
            <td>SGSH</td>
            
            
            
        </tr>
        <tr>
            <td>354</td>
            <td>Gitelman Syndrome</td>
            <td>SLC12A3</td>
            
            
            
        </tr>
        <tr>
            <td>355</td>
            <td>Agenesis of the Corpus Callosum with Peripheral  Neuropathy (Andermann Syndrome)</td>
            <td>SLC12A6</td>
            
            
            
        </tr>
        <tr>
            <td>356</td>
            <td>Salla Disease</td>
            <td>SLC17A5</td>
            
            
            
        </tr>
        <tr>
            <td>357</td>
            <td>Megaloblastic Anemia Syndrome</td>
            <td>SLC19A2</td>
            
            
            
        </tr>
        <tr>
            <td>358</td>
            <td>Carnitine Deficiency</td>
            <td>SLC22A5</td>
            
            
            
        </tr>
        <tr>
            <td>359</td>
            <td>Citrullinemia, Type II</td>
            <td>SLC25A13</td>
            
            
            
        </tr>
        <tr>
            <td>360</td>
            <td>Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome</td>
            <td>SLC25A15</td>
            
            
            
        </tr>
        <tr>
            <td>361</td>
            <td>Carnitine-acylcarnitine translocase deficiency</td>
            <td>SLC25A20</td>
            
            
            
        </tr>
        <tr>
            <td>362</td>
            <td>Achondrogenesis, Type 1B</td>
            <td>SLC26A2</td>
            
            
            
        </tr>
        <tr>
            <td>363</td>
            <td>Congenital Chloride Diarrhea</td>
            <td>SLC26A3</td>
            
            
            
        </tr>
        <tr>
            <td>364</td>
            <td>Pendred Syndrome</td>
            <td>SLC26A4</td>
            
            
            
        </tr>
        <tr>
            <td>365</td>
            <td>Autism Spectrum, Epilepsy and Arthrogryposis</td>
            <td>SLC35A3</td>
            
            
            
        </tr>
        <tr>
            <td>366</td>
            <td>Glycogen Storage Disease, Type IB</td>
            <td>SLC37A4</td>
            
            
            
        </tr>
        <tr>
            <td>367</td>
            <td>Acrodermatitis Enteropathica</td>
            <td>SLC39A4</td>
            
            
            
        </tr>
        <tr>
            <td>368</td>
            <td>Oculocutaneous albinism, Type 4</td>
            <td>SLC45A2</td>
            
            
            
        </tr>
        <tr>
            <td>369</td>
            <td>Corneal Dystrophy and Perceptive Deafness</td>
            <td>SLC4A11</td>
            
            
            
        </tr>
        <tr>
            <td>370</td>
            <td>Creatine Transporter Defect (Cerebral Creatine Deficiency Syndrome 1, X-Linked)</td>
            <td>SLC6A8</td>
            
            
            
        </tr>
        <tr>
            <td>371</td>
            <td>Lysinuric Protein Intolerance</td>
            <td>SLC7A7</td>
            
            
            
        </tr>
        <tr>
            <td>372</td>
            <td>Cystinuria, Type B</td>
            <td>SLC7A9</td>
            
            
            
        </tr>
        <tr>
            <td>373</td>
            <td>Schimke Immunoosseous Dysplasia</td>
            <td>SMARCAL1</td>
            
            
            
        </tr>
        <tr>
            <td>374</td>
            <td>Niemann-Pick Disease, Types A/B</td>
            <td>SMPD1</td>
            
            
            
        </tr>
        <tr>
            <td>375</td>
            <td>5-alpha reductase deficiency</td>
            <td>SRD5A2</td>
            
            
            
        </tr>
        <tr>
            <td>376</td>
            <td>GM3 synthase deficiency</td>
            <td>ST3GAL5</td>
            
            
            
        </tr>
        <tr>
            <td>377</td>
            <td>Lipoid Congenital Adrenal Hyperplasia</td>
            <td>STAR</td>
            
            
            
        </tr>
        <tr>
            <td>378</td>
            <td>Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)</td>
            <td>SUCLA2</td>
            
            
            
        </tr>
        <tr>
            <td>379</td>
            <td>Multiple Sulfatase Deficiency</td>
            <td>SUMF1</td>
            
            
            
        </tr>
        <tr>
            <td>380</td>
            <td>Leigh Syndrome</td>
            <td>SURF1</td>
            
            
            
        </tr>
        <tr>
            <td>381</td>
            <td>Tyrosinemia, Type II</td>
            <td>TAT</td>
            
            
            
        </tr>
        <tr>
            <td>382</td>
            <td>Osteopetrosis, Infantile Malignant, TCIRG1-Related</td>
            <td>TCIRG1</td>
            
            
            
        </tr>
        <tr>
            <td>383</td>
            <td>Hereditary Spastic Paraparesis, Type 49</td>
            <td>TECPR2</td>
            
            
            
        </tr>
        <tr>
            <td>384</td>
            <td>Hemochromatosis, Type 3, TFR2-Related</td>
            <td>TFR2</td>
            
            
            
        </tr>
        <tr>
            <td>385</td>
            <td>Lamellar Ichthyosis, Type 1</td>
            <td>TGM1</td>
            
            
            
        </tr>
        <tr>
            <td>386</td>
            <td>Segawa Syndrome, TH-Related</td>
            <td>TH</td>
            
            
            
        </tr>
        <tr>
            <td>387</td>
            <td>Deafness, autosomal dominant 36, autosomal recessive 7</td>
            <td>TMC1</td>
            
            
            
        </tr>
        <tr>
            <td>388</td>
            <td>Joubert Syndrome 2 / Meckel Syndrome 2</td>
            <td>TMEM216</td>
            
            
            
        </tr>
        <tr>
            <td>389</td>
            <td>Congenital hypothyroidism</td>
            <td>TPO</td>
            
            
            
        </tr>
        <tr>
            <td>390</td>
            <td>Ceroid Lipofuscinosis, Neuronal, 2</td>
            <td>TPP1</td>
            
            
            
        </tr>
        <tr>
            <td>391</td>
            <td>Aicardi-Goutieres syndrome, TREX1-related</td>
            <td>TREX1</td>
            
            
            
        </tr>
        <tr>
            <td>392</td>
            <td>Bardet-Biedl syndrome 11</td>
            <td>TRIM32</td>
            
            
            
        </tr>
        <tr>
            <td>393</td>
            <td>Mulibrey nanism syndrome</td>
            <td>TRIM37</td>
            
            
            
        </tr>
        <tr>
            <td>394</td>
            <td>Acute Infantile Liver Failure, TRMU-Related</td>
            <td>TRMU</td>
            
            
            
        </tr>
        <tr>
            <td>395</td>
            <td>Pontocerebellar hypoplasia</td>
            <td>TSEN54</td>
            
            
            
        </tr>
        <tr>
            <td>396</td>
            <td>Combined Oxidative Phosphorylation Deficiency 3</td>
            <td>TSFM</td>
            
            
            
        </tr>
        <tr>
            <td>397</td>
            <td>Congenital hypothyroidism</td>
            <td>TSHB</td>
            
            
            
        </tr>
        <tr>
            <td>398</td>
            <td>Hypothyroidism, congenital, nongoitrous, 1</td>
            <td>TSHR</td>
            
            
            
        </tr>
        <tr>
            <td>399</td>
            <td>Tricho-Hepato-Enteric Syndrome</td>
            <td>TTC37</td>
            
            
            
        </tr>
        <tr>
            <td>400</td>
            <td>Familial dilated cardiomyopathy</td>
            <td>TTN</td>
            
            
            
        </tr>
        <tr>
            <td>401</td>
            <td>Ataxia with Vitamin E Deficiency</td>
            <td>TTPA</td>
            
            
            
        </tr>
        <tr>
            <td>402</td>
            <td>Myoneurogastrointestinal Encephalopathy (MNGIE)</td>
            <td>TYMP</td>
            
            
            
        </tr>
        <tr>
            <td>403</td>
            <td>Oculocutaneous Albinism, Type 1</td>
            <td>TYR</td>
            
            
            
        </tr>
        <tr>
            <td>404</td>
            <td>Oculocutaneous albinism, Type 3</td>
            <td>TYRP1</td>
            
            
            
        </tr>
        <tr>
            <td>405</td>
            <td>Crigler-Najjar Syndrome</td>
            <td>UGT1A1</td>
            
            
            
        </tr>
        <tr>
            <td>406</td>
            <td>Beta-ureidopropionase deficiency</td>
            <td>UPB1</td>
            
            
            
        </tr>
        <tr>
            <td>407</td>
            <td>Usher Syndrome, Type 1C</td>
            <td>USH1C</td>
            
            
            
        </tr>
        <tr>
            <td>408</td>
            <td>Cohen Syndrome</td>
            <td>VPS13B</td>
            
            
            
        </tr>
        <tr>
            <td>409</td>
            <td>Congenital Neutropenia, VPS45-Related</td>
            <td>VPS45</td>
            
            
            
        </tr>
        <tr>
            <td>410</td>
            <td>Pontocerebellar Hypoplasia, Type 2E</td>
            <td>VPS53</td>
            
            
            
        </tr>
        <tr>
            <td>411</td>
            <td>Pontocerebellar Hypoplasia, Type 1A</td>
            <td>VRK1</td>
            
            
            
        </tr>
        <tr>
            <td>412</td>
            <td>Microphthalmia/Anophthalmia, VSX2-Related</td>
            <td>VSX2</td>
            
            
            
        </tr>
        <tr>
            <td>413</td>
            <td>Von Willebrand disease</td>
            <td>VWF</td>
            
            
            
        </tr>
        <tr>
            <td>414</td>
            <td>Wiskott-Aldrich syndrome, X-Linked</td>
            <td>WAS</td>
            
            
            
        </tr>
        <tr>
            <td>415</td>
            <td>Progressive Pseudorheumatoid Dysplasia</td>
            <td>WISP3</td>
            
            
            
        </tr>
        <tr>
            <td>416</td>
            <td>Odonto-Onycho-Dermal Dysplasia / Schopf-Schulz-Passarge Syndrome</td>
            <td>WNT10A</td>
            
            
            
        </tr>
        <tr>
            <td>417</td>
            <td>Werner Syndrome</td>
            <td>WRN</td>
            
            
            
        </tr>
        <tr>
            <td>418</td>
            <td>Xeroderma pigmentosum Group A</td>
            <td>XPA</td>
            
            
            
        </tr>
        <tr>
            <td>419</td>
            <td>Xeroderma Pigmentosum Group C</td>
            <td>XPC</td>
            
            
            
        </tr>
        <tr>
            <td>420</td>
            <td>Spastic Paraplegia Type 15</td>
            <td>ZFYVE26</td>
            
    
        </tr>
    
</tbody>
    </table>
  </div>
  <script src="script.js"></script>
</body>
</html>
